Everyday cognitive failure in patients suffering from neurosarcoidosis

Cognitive failure is associated with memory and concentration problems. Previously, a prevalence of one third was found in a general sarcoidosis population. The aim of this study was to assess if neurosarcoidosis patients are at higher risk for developing everyday cognitive failure using the Cogniti...

Full description

Saved in:
Bibliographic Details
Published in:Sarcoidosis, vasculitis, and diffuse lung diseases vasculitis, and diffuse lung diseases, 2019-01, Vol.36 (1), p.2-10
Main Authors: Voortman, Mareye, De Vries, Jolanda, Hendriks, Celine M R, Elfferich, Marjon D P, Wijnen, Petal A H M, Drent, Marjolein
Format: Article
Language:English
Subjects:
Adult
Aged
Attention
Case-Control Studies
Central Nervous System Diseases - diagnosis
Central Nervous System Diseases - epidemiology
Cognition
Cognitive Dysfunction - diagnosis
Cognitive Dysfunction - epidemiology
Cognitive Dysfunction - psychology
Cross-Sectional Studies
Fatigue - epidemiology
Female
Humans
Male
Memory
Memory Disorders - diagnosis
Memory Disorders - epidemiology
Memory Disorders - psychology
Middle Aged
Netherlands - epidemiology
Original article: Clinical research
Prevalence
Prognosis
Risk Factors
Sarcoidosis - diagnosis
Sarcoidosis - epidemiology
Small Fiber Neuropathy - epidemiology
Young Adult
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cognitive failure is associated with memory and concentration problems. Previously, a prevalence of one third was found in a general sarcoidosis population. The aim of this study was to assess if neurosarcoidosis patients are at higher risk for developing everyday cognitive failure using the Cognitive Failure Questionnaire (CFQ) and to determine what factors were associated with cognitive failure. A cross-sectional web-based survey was conducted from April to May 2017 in a national sample of neurosarcoidosis patients. The survey asked about complaints and included 3 questionnaires (Fatigue Assessment Scale [FAS], Small Fiber Neuropathy Screening List [SFNSL] and CFQ. Data were compared to a general sarcoidosis population. Of the 152 patients who completed the survey, 131 had neurosarcoidosis. The mean CFQ score was significantly higher in the neurosarcoidosis (45.6±20.7) compared to the general sarcoidosis population (36.2±15.9; p< 0.0001). High CFQ scores (≥43) were found in 55.7% and 33.9%, respectively (p
ISSN:1124-0490
2532-179X
DOI:10.36141/svdld.v36i1.7412